Tuesday, March 27, 2012

Good news for ageing Indian patients with aortic valve disease


This year’s WHO slogan focuses on ageing and health. The title is important to India in view of its increasing ageing population.  More and more people are toady crossing the age barrier due to advancements in medical fields.

Recently India saw 2 advancements in elderly population with heart disease called aortic stenosis where one of the valves gets narrowed and reduces the life span.

Firstly Padamshri Professor Jagdish Prasad, Chief Cardio Thoracic Surgeon & DGHS implanted a tissue bovine pericardial artificial aortic
‘Trifecta’ valve successfully to a patient at Safdarjang hospital. The valve is the most advanced pericardial aortic stented tissue valve design available by St. Jude Medical, a global medical device company.

The newest Trifecta valve is a clinically proven replacement valve designed for patients with diseased, damaged or malfunctioning aortic
heart valves. The next-generation tissue valve has a tri-leaflet stented pericardial design that offers excellent hemodynamic performance (circulation and flow of blood through the valve) and long-term durability.

We have been eagerly anticipating the launch of the Trifecta valve in India and pleased to report the first successful implant of the same
said Dr Prasad. The valve will offer numerous benefits to the patients
including a durable design that reduces stress on the valve and allows it to last longer, and exceptional hemodynamic performance that allows the valve to perform more like a natural heart valve, which will allow patients to live a more active life.

The valve is constructed using a polyester and tissue-covered titanium stent, or base, to ensure structural integrity of the valve.
The valve features leaflets manufactured from pericardial tissue attached to the exterior of the valve stent. This design allows the leaflets to open more fully and efficiently, mimicking the performance of a healthy aortic heart valve, while also mitigating tissue abrasion through tissue-to-tissue (stent-to-leaflet) contact, said Dr Yugal Mishra from Fortis Escorts Heart Institute.

Also for those who are not fit for surgery India now has another alternative. A few weeks back Fortis Escorts Heart Institute launched replacement of the valve without surgery via a catheter.